Search Results 721-730 of 18202 for Crohns disease
And it's quite conceivable that inflammatory bowel disease patients could get this at a higher risk also.
Natalizumab-sztn injection is also used to treat moderate to severe Crohn's disease (CD) when other medicines or treatments did not work well. This medicine ...
... diseases such as type 1 diabetes, inflammatory bowel disease and arthritis. Fibroproliferative disorders cause organ fibrosis and cirrhosis — the process of ...
... inflammatory bowel disease (IBD),post-surgical patients with an increased risk of developing paralytic postoperative ileus (POI), and patients with evidence ...
A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment - ...
These specialty clinics focus on specific organs (for example, liver and pancreas) or diseases (for example, colon cancer, inflammatory bowel disease and ...
... and Efficacy of Vedolizumab Subcutaneous in Subjects With Ulcerative Colitis and Crohn's Disease (Vedolizulmab 3030) Vedolizumab Subcutaneous Long-Term Open ...
... Crohn's disease in children 6 years of age and older. However, safety ... Crohn's disease, and in children for other conditions. Geriatric. Appropriate ...
A Study to Evaluate the Prevalence and Impact of Eating Disorders Among Patients with Inflammatory Bowel Disease. Jacksonville, Fla. The purpose of this ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.